BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 13, 2010
 |  BC Week In Review  |  Company News  |  Other News

Momenta, Teva, Novartis autoimmune news

The U.S. District Court for the Southern District of New York denied a motion for summary judgment filed by Novartis' Sandoz International GmbH generics unit and Momenta alleging that Teva's patents covering Copaxone...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >